Status:
COMPLETED
Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation
Lead Sponsor:
Imam Khomeini Hospital
Conditions:
End Stage Renal Disease
Renal Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Cyclosporine is the key drug in organ transplantation. In Iran the investigators have more than 2500 new renal transplantation each year and because of this the government pay a huge amount of money f...
Eligibility Criteria
Inclusion
- renal transplantation candidates
- written consent
- not taking participate in any other clinical trial in last 3 months
Exclusion
- primary FSGS
- hyperoxaluria
- age under 18
- multi organ transplantation
- any malignancy in 5 years
- PRA \> 25%
- use of Tacrolimus
- hyper acute rejection
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT00656695
Start Date
April 1 2008
End Date
October 1 2009
Last Update
June 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imam Khomeini Hospital
Tehran, Iran